Alcohol Drinking: Clinical Trials

55 trials for Alcohol Drinking, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

55 completed. 55 Phase 2, 11 Phase 1, 3 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 255Completed 55
Phase 111Completed 11
Phase 33Completed 3

Follow Alcohol Drinking: new trials by email Literature Review of Alcohol Drinking trials Research Report on Alcohol Drinking

Trials (filtered) newest first · largest first

All 55 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Study of Sunobinop on Alcohol Consumption in Alcohol Use Disorder
Sunobinop, Placebo to match sunobinop - Alcohol Use Disorder
Phase 2CompletedKnoa Pharma LLC2092024-10-142026-06-05
Metabolic Changes Induced by NMN in Healthy Subjects With Acute Binge Drink
β-nicotinamide Mononucleotide, Maltodextrin - Binge Drinking, Liver Injury
Phase 1 / Phase 2CompletedZhejiang Chinese Medical University222024-05-012025-04-10
Semaglutide Therapy for Alcohol Reduction - Tulsa
Semaglutide, Placebo - Alcohol Use Disorder
Phase 2CompletedOklahoma State University Center for Health Sciences802023-07-072025-12-17
Probiotics, Immune Function, and the Brain in Alcohol Consumers
Seed DS-01 Daily Synbiotic - Alcohol; Use, Problem
Phase 2CompletedBrown University322022-02-242024-09-19
Human Laboratory Study of ASP8062 for Alcohol Use Disorder
ASP8062, Placebo - Alcohol Use Disorder, Alcohol Drinking
Phase 2CompletedNational Institute on Alcohol Abuse and Alcoholism (NIAAA)602021-12-132024-12-03
Opioid Modulation and Neural Reward Activation in Healthy Adults
Naltrexone, Placebo - Alcohol Drinking, Opioid Use, Unspecified
Phase 1 / Phase 2CompletedUniversity of Colorado, Denver132021-05-012023-11-28
Role of BP1.3656 on Alcohol Responses
BP1.3656, Placebo - Alcohol Use Disorder
Phase 2CompletedCentre for Addiction and Mental Health372021-02-012023-04-05
St. PETERsburg Pain and Alcohol Intervention With Naltrexone and Gabapentin
Low-dose naltrexone, Gabapentin, Placebo - Chronic Pain, Alcohol Use, Unspecified
Phase 2CompletedBoston Medical Center452021-01-252022-11-10
Timing Personalized Feedback After Alcohol Health Education
e-checkup to go, Feedback booster - College Student Drinking
Phase 1 / Phase 2CompletedAbby Braitman1952020-11-302023-05-03
St. PETERsburg Pain and Alcohol Intervention With Naltrexone and Nalmefene
Low dose naltrexone, Nalmefene - HIV Infection, Alcohol Use
Phase 1 / Phase 2CompletedBoston Medical Center112018-07-032020-08-24
Effect of GET73 on MRS Measures of Central Glutamate and GABA in Individuals With Alcohol Use Disorder
GET73, Placebo - Alcohol Use Disorder
Phase 2CompletedLaboratorio Farmaceutico Ct S.r.l.242018-03-082020-10-08
Personalized Booster Feedback After Alcohol Health Education
e-checkup to go, Feedback-only booster, Feedback-plus-personal-contact booster - College Student Drinking
Phase 1 / Phase 2CompletedAbby Braitman2492018-02-192022-06-30
Alkontrol-herbal Effects on Alcohol Drinking
kudzu extract, puerarin, Placebo control - Alcohol Drinking, Alcohol Use Disorder
Phase 2CompletedMclean Hospital282018-01-012020-07-29
Neuroscience-Informed Treatment Development for Adolescent Alcohol Use
N-Acetylcysteine, Placebo Oral Capsule - Alcohol Drinking, Control
Phase 2CompletedMedical University of South Carolina572017-10-162023-06-22
Studying Partial-agonists for Ethanol and Tobacco Elimination in Russians With HIV (St PETER HIV)
Varenicline, Cytisine, Nicotine Replacement Therapy - HIV Infection, Alcohol Use
Phase 2 / Phase 3CompletedBoston Medical Center4002017-07-192020-12-17
Oxytocin, Alcohol Craving, and Intimate Partner Aggression
Oxytocin, Placebo - Alcohol Use
Phase 2CompletedMedical University of South Carolina2002017-07-012022-05-09
Saracatinib and Alcohol Drinking
Saracatinib, Placebos - Alcohol Drinking
Phase 2CompletedYale University502017-05-092020-11-13
Alcohol Health Education With Personalized Feedback Boosters
e-checkup to go, Norms-only booster, Norms-plus-Strategies booster - College Student Drinking
Phase 1 / Phase 2CompletedAbby Braitman5282017-04-112023-06-22
Marijuana's Impact on Alcohol Motivation and Consumption
THC 7.2%, THC 3.1%, Placebo - Alcohol Drinking, Marijuana
Phase 2CompletedBrown University1572017-01-232026-04-21
Collaborative Care for Alcohol Use Disorders in the Patient-centered Medical Home
Motivation Enhancement Therapy, Modified Behavioral Self-Control Therapy, Naltrexone - Alcohol-Related Disorders, Alcohol Drinking
Phase 1 / Phase 2CompletedNorthwell Health272017-01-012023-10-30

Showing 20 of 55. Sign in to see all of them.

Narrower conditions

Alcoholism (23)  ·  Alcohol-Related Disorders (5)  ·  Behavior, Addictive (5)  ·  Binge Drinking (5)  ·  Depression (5)  ·  Substance-Related Disorders (5)  ·  HIV Infections (4)  ·  Alcohol Drinking in College (3)  ·  Anxiety Disorders (3)  ·  Drinking Behavior (3)  ·  Smoking (3)  ·  Smoking Cessation (3)  ·  Alcoholic Intoxication (2)  ·  Cigarette Smoking (2)

Broader conditions

Behavior (55)  ·  Drinking Behavior (52)  ·  Mental Disorders (32)  ·  Chemically-Induced Disorders (31)  ·  Substance-Related Disorders (27)  ·  Alcohol-Related Disorders (23)  ·  Behavioral Symptoms (6)  ·  Pathological Conditions, Signs and Symptoms (6)  ·  Compulsive Behavior (5)  ·  Impulsive Behavior (5)  ·  Signs and Symptoms (5)  ·  Urogenital Diseases (5)  ·  Blood-Borne Infections (4)  ·  Communicable Diseases (4)

Interventions

Naltrexone (8)  ·  Ethanol (6)  ·  Varenicline (5)  ·  Baclofen (2)  ·  Bupropion (2)  ·  Crisis Intervention (2)  ·  Sugars (2)  ·  Tobacco Use Cessation Devices (2)  ·  1-(((alpha-isobutanoyloxyethoxy)carbonyl)aminomethyl)-1-cyclohexaneacetic acid (1)  ·  ASP8062 (1)  ·  Acetylcysteine (1)  ·  Counseling (1)  ·  Cyproheptadine (1)  ·  Ecological Momentary Assessment (1)  ·  Gabapentin (1)

Sponsors

National Institute on Alcohol Abuse and Alcoholism (NIAAA) (7)  ·  Yale University (7)  ·  Boston Medical Center (4)  ·  Brown University (4)  ·  Abby Braitman (3)  ·  Centers for Disease Control and Prevention (2)  ·  Mclean Hospital (2)  ·  Medical University of South Carolina (2)  ·  Boston University (1)  ·  Centre for Addiction and Mental Health (1)  ·  Danish Cancer Society (1)  ·  Institut fuer anwendungsorientierte Forschung und klinische Studien GmbH (1)  ·  Iowa City Veterans Affairs Medical Center (1)  ·  King's College London (1)  ·  Knoa Pharma LLC (1)

Countries

United States (46)  ·  Russia (3)  ·  Canada (1)  ·  China (1)  ·  Denmark (1)  ·  Germany (1)  ·  Romania (1)  ·  South Africa (1)  ·  United Kingdom (1)

Top investigators

Abby L Braitman, Ph.D. (3)  ·  Sherry A McKee, PhD (3)  ·  Jeffrey H. Samet, MD, MA, MPH (2)  ·  Lorenzo Leggio, M.D. (2)  ·  Suchitra Krishnan-Sarin, Ph.D. (2)  ·  Allen Zweben, PhD (1)  ·  Bernhard Croissant, MD PhD (1)  ·  Christoffer Johansen, M.D., Ph.D. (1)  ·  Elizabeth J. D'Amico, PhD (1)  ·  Glenn-Milo Santos, PhD (1)  ·  James Garbutt (1)  ·  Jane Metrik, PhD (1)  ·  Jeffrey H Samet, MA, MA, MPH (1)  ·  Jiaomei Li (1)  ·  Joanne E Fertig, Ph.D. (1)

Results publications

PMID 41329966, PMID 20048226, PMID 20732631, PMID 20869813, PMID 21134017, PMID 22324516, PMID 22592966, PMID 23262301, PMID 23265707, PMID 23282113, PMID 24766757, PMID 24814717, PMID 25086446, PMID 25752972, PMID 25888856, PMID 26048637, PMID 26254687, PMID 26675247, PMID 26946991, PMID 27062270, PMID 27535024, PMID 27936818, PMID 28440812, PMID 29133954, PMID 29261824, PMID 29389170, PMID 29843074, PMID 30817018, PMID 30865304, PMID 33682527, PMID 34081487, PMID 34766785, PMID 35930287, PMID 37142273, PMID 37530456, PMID 38408060, PMID 40392716, PMID 41129363, PMID 41254853, PMID 42400312

NIH funding

K01AA023849 (3), P50AA012870 (3), R01AA015596 (2), 1DP5OD019809 (1), K23AA025399 (1), P01AA019072 (1), P60AA013759 (1), R01AA012518 (1), R01AA013895 (1), R01AA013990 (1), R01AA018076 (1), R01AA020388 (1), R01AA022285 (1), R01AA024091 (1), R21AA023368 (1)